Literature DB >> 3134227

Protein patterns, serotyping and plasmid DNA profiles in the epidemiologic fingerprinting of Pseudomonas aeruginosa.

S Walia1, T Madhavan, T Williamson, A Kaiser, R Tewari.   

Abstract

The epidemiological typing schemes based on serotyping, antibiotic susceptibility pattern, plasmid DNA profile, and protein patterns determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were evaluated for their usefulness in typing clinical isolates of Pseudomonas aeruginosa. The serotypability was lower (45%) than reported in the literature (85-95%). The most commonly found serotypes were O:1 (19%), O:11 (25%), O:6 (35%). The electrophoretic analysis of plasmid DNAs showed plasmids (molecular weight = 1 to greater than 40 megadaltons). Two plasmids of Mr 2 and 38 megadaltons were found in various serotypes. The restriction enzyme analysis of plasmid DNA showed identical DNA fragment patterns among distinct serotypes. The SDS-PAGE protein banding patterns of whole-cell proteins showed homogeneity among the strains. However, analysis of the soluble protein patterns of the strains showed sufficiently distinct protein profiles that can be used to differentiate between various strains. The results of this study demonstrate that the electrophoretic patterns of soluble proteins, in combination with plasmid DNA profile or serotyping, can be of value in the epidemiologic fingerprinting of clinical isolates of Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134227     DOI: 10.1007/bf01963096

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Polyacrylamide slab gel electrophoresis of soluble proteins for studies of bacterial floras.

Authors:  W E Moore; D E Hash; L V Holdeman; E P Cato
Journal:  Appl Environ Microbiol       Date:  1980-04       Impact factor: 4.792

2.  Antibiograms, serotypes, and plasmid profiles of Pseudomonas aeruginosa associated with corneal ulcers and contact lens wear.

Authors:  M S Mayo; W L Cook; R L Schlitzer; M A Ward; L A Wilson; D G Ahearn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

3.  Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

Authors:  N J Legakis; M Aliferopoulou; J Papavassiliou; M Papapetropoulou
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

4.  Phage typing of Pseudomonas aeruginosa: clinical and epidemiologic considerations.

Authors:  R B Lindberg; R L Latta
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

5.  Microscopic agglutination and polyacrylamide gel electrophoresis analyses of oral anaerobic spirochetes.

Authors:  B D Tall; R K Nauman
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

6.  Epidemiology of pseudomonas aeruginosa in a burn hospital: evaluation of serological, bacteriophage, and pyocin typing methods.

Authors:  P Edmonds; R R Suskind; B G Macmillan; I A Holder
Journal:  Appl Microbiol       Date:  1972-08

7.  Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool.

Authors:  J M Janda; E J Bottone
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

8.  Nosocomial bacteriuria: a prospective study of case clustering and antimicrobial resistance.

Authors:  D R Schaberg; R W Haley; A K Highsmith; R L Anderson; J E McGowan
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

9.  Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11.

Authors:  J J Farmer; R A Weinstein; C H Zierdt; C D Brokopp
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

10.  Sodium dodecyl sulfate-polyacrylamide gel typing system for characterization of Neisseria meningitidis isolates.

Authors:  L F Mocca; C E Frasch
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

View more
  8 in total

1.  Genotypic homogeneity of nosocomial Pseudomonas aeruginosa O12 strains demonstrated by analysis of protein profiles, DNA fingerprints and rRNA gene restriction patterns.

Authors:  F Grattard; O G Gaudin; B Pozzetto; A Ros; A D Mbida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

2.  Molecular cloning of 3-phenylcatechol dioxygenase involved in the catabolic pathway of chlorinated biphenyl from Pseudomonas putida and its expression in Escherichia coli.

Authors:  A Khan; R Tewari; S Walia
Journal:  Appl Environ Microbiol       Date:  1988-11       Impact factor: 4.792

3.  Comparison of SDS-PAGE protein patterns with other typing methods for investigating the epidemiology of 'Klebsiella aerogenes'.

Authors:  M Costas; B Holmes; L L Sloss
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

4.  The use of SDS polyacrylamide gel electrophoresis of periplasmic proteins to subtype Pseudomonas aeruginosa pyocin type 10/b clinical isolates.

Authors:  K Adwan
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

5.  Pseudomonas aeruginosa clinical isolates: serotypes, resistance phenotypes and plasmid profiles.

Authors:  M Millesimo; G de Intinis; M G Chirillo; T Musso; D Savoia
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

6.  Cloning of bacterial genes specifying degradation of 4-chlorobiphenyl from Pseudomonas putida OU83.

Authors:  A Khan; S Walia
Journal:  Appl Environ Microbiol       Date:  1989-04       Impact factor: 4.792

7.  Involvement of a large plasmid in the degradation of 1,2-dichloroethane by Xanthobacter autotrophicus.

Authors:  G Tardif; C W Greer; D Labbé; P C Lau
Journal:  Appl Environ Microbiol       Date:  1991-06       Impact factor: 4.792

8.  Evaluation of numerical analysis of SDS-PAGE of protein patterns for typing Enterobacter cloacae.

Authors:  M Costas; L L Sloss; R J Owen; M A Gaston
Journal:  Epidemiol Infect       Date:  1989-10       Impact factor: 2.451

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.